Dr Richard Carvajal Describes MEK Inhibition in Uveal Melanoma
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=z3rdfgkmNns
Richard D. Carvajal, MD, a medical oncologist at Memorial Sloan-Kettering Cancer Center, describes the success of MEK inhibition in patients with advanced uveal melanoma using the agent selumetinib. • These data were presented at the 2013 ASCO Annual Meeting. For more from this meeting, visit http://www.onclive.com/conference-cov...
#############################
![](http://youtor.org/essay_main.png)